Atypical pathogen community-acquired pneumonia: an analysis of clinical characteristics, drug treatment, and prognosis in the related patients
Authors:
- 14 March 2025
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-14
Abstract
Introduction Serious respiratory infections can occur in both in-hospital and out-of-hospital settings. These infections are known as community-acquired pneumonias (CAPs). Streptococcus pneumoniae and other microorganisms commonly cause atypical pneumonia. This study examined the clinical features, medication therapy, and prognosis of 85 cases of community-acquired pneumonia (CAP) caused by Mycoplasma pneumoniae (MPP) and Chlamydia psittaci(C. psittaci)neumoniae (CPP). Methods A retrospective analysis was conducted at Shaoxing People’s Hospital from July 2021 to August 2024, using targeted next-generation sequencing (tNGS) of bronchoalveolar lavage fluid (BALF). Patients were classified into the MPP group (54 patients) and the CPP group (31 patients). Compared with the control group, the CPP group had a significantly lower proportion of patients with a contact history of poultry and birds, a shorter length of hospital stay, and a lower percentage of severe pneumonia cases. Results The MPP group demonstrated higher incidences of cough and sputum production; conversely, the occurrences of fever, fatigue, diminished appetite, and generalised myalgia were comparatively lower. The MPP group exhibited markedly diminished levels of neutrophils, C-reactive protein, procalcitonin, erythrocyte sedimentation rate, heparin-binding protein, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, direct bilirubin, pH, lactic acid, and D-dimer compared with the CPP group. In contrast, the MPP group had a markedly higher lymphocyte count, platelet count, albumin levels, as well as higher concentrations of blood sodium and blood chloride. The drug treatment regimens differed between the two groups, resulting in one unfavourable outcome within the MPP group. Conclusion In summary, fatigue, fever, and reduced appetite are more prominent symptoms in patients with CPP, whereas cough and sputum production are the primary manifestations of MPP. Pleural effusion is more prevalent in patients with CPP, Additionally, these patients also have increased inflammatory responses and decreased immune function.Keywords
This publication has 63 references indexed in Scilit:
- Community-Acquired PneumoniaJAMA, 2024
- In vitro and in vivo immunomodulatory activity of acetylated polysaccharides from Cyclocarya paliurus leavesInternational Journal of Biological Macromolecules, 2024
- Toxic effects and toxicological mechanisms of chlorinated paraffins: A review for insight into species sensitivity and toxicity differenceEnvironment International, 2023
- ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumoniaIntensive Care Medicine, 2023
- Utilizing Metagenomic Next-Generation Sequencing (mNGS) for Rapid Pathogen Identification and to Inform Clinical Decision-Making: Results from a Large Real-World CohortInfectious Diseases and Therapy, 2023
- Long Life Strategy2023
- The Role of Endoplasmic Reticulum Chaperones in Protein Folding and Quality Control2021
- Correlations between Serum P2X7, Vitamin A, 25‐hydroxy Vitamin D, and Mycoplasma Pneumoniae PneumoniaJournal of Clinical Laboratory Analysis, 2021
- Atypical and Typical Bacteria in Children with Community Acquired Pneumonia2019
- Respiratory Infections2019